Keybanc Maintains Overweight on LifeStance Health Gr, Raises Price Target to $15
Benzinga Newsdesk 3 weeks ago
Analyst RatingsNewsPrice Target
Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.
Keybanc analyst Steve Dechert maintains LifeStance Health Gr (NASDAQ:LFST) with a Overweight and raises the price target from $13 to $15.